KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $1.0 million.

  • Precigen's Other Operating Expenses rose 257.68% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 7174.33%. This contributed to the annual value of $44.6 million for FY2024, which is 16301.17% up from last year.
  • As of Q3 2025, Precigen's Other Operating Expenses stood at $1.0 million, which was up 257.68% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Other Operating Expenses registered a high of $35.6 million during Q2 2024, and its lowest value of $1.0 million during Q3 2024.
  • Its 5-year average for Other Operating Expenses is $4.9 million, with a median of $1.6 million in 2021.
  • As far as peak fluctuations go, Precigen's Other Operating Expenses crashed by 8781.06% in 2021, and later skyrocketed by 199540.37% in 2024.
  • Precigen's Other Operating Expenses (Quarter) stood at $1.6 million in 2021, then fell by 20.49% to $1.3 million in 2022, then soared by 870.01% to $12.2 million in 2023, then tumbled by 43.02% to $6.9 million in 2024, then plummeted by 85.1% to $1.0 million in 2025.
  • Its Other Operating Expenses stands at $1.0 million for Q3 2025, versus $5.0 million for Q2 2025 and $1.1 million for Q1 2025.